{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:49:46Z","timestamp":1790502586876,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007613","name":"Majmaah University","doi-asserted-by":"publisher","award":["64\/28595"],"award-info":[{"award-number":["64\/28595"]}],"id":[{"id":"10.13039\/501100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.intimp.2021.107493","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T20:22:47Z","timestamp":1614198167000},"page":"107493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis \u2013 An updated review"],"prefix":"10.1016","volume":"95","author":[{"given":"Eijaz Ahmed","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johra","family":"khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreena","family":"Sajjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad M.","family":"Aldakheel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Mateen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabbani","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107493_b0005","unstructured":"World Health Organization. \u201cBlueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens.\u201d WHO, Geneva, Switzerland, 7 (2015)."},{"key":"10.1016\/j.intimp.2021.107493_b0010","unstructured":"World Health Organization. \u201cPrioritizing diseases for research and development in emergency contexts.\u201d (2019)."},{"issue":"63","key":"10.1016\/j.intimp.2021.107493_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"257","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.intimp.2021.107493_b0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmv.25682","article-title":"Cross-species transmission of the newly identified coronavirus 2019-nCoV","volume":"92","author":"Ji","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2021.107493_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107493_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2021.107493_b0035","article-title":"The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.intimp.2021.107493_b0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/22221751.2020.1723441","article-title":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies","volume":"9","author":"Jiang","year":"2020","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.intimp.2021.107493_b0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. Lancet"},{"key":"10.1016\/j.intimp.2021.107493_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)30419-0","article-title":"A distinct name is needed for the new coronavirus","author":"Jiang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107493_b0055","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: Global initiative on sharing all influenza data\u2013from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill."},{"key":"10.1016\/j.intimp.2021.107493_b0060","unstructured":"WHO. Coronavirus disease 2019 (COVID-19) situation report-32 (accessed 21 February 2020). https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situationreports\/20200221-sitrep-32-covid-19.pdf?sfvrsn=4802d089_2."},{"key":"10.1016\/j.intimp.2021.107493_b0065","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","author":"Qamar","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.intimp.2021.107493_b0070","unstructured":"WHO. Weekly epidemiological update - 5 January 2021. (2021), https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update---5-january-2021."},{"key":"10.1016\/j.intimp.2021.107493_b0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: Genome structure, replication, and 265 pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"12","key":"10.1016\/j.intimp.2021.107493_b0080","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1128\/JVI.02501-05","article-title":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex","volume":"80","author":"Snijder","year":"2006","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.intimp.2021.107493_b0085","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1128\/JVI.79.9.5288-5295.2005","article-title":"Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus","volume":"79","author":"Hussain","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107493_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JVI.01358-06","article-title":"A contemporary view of coronavirus transcription","volume":"81","author":"Sawicki","year":"2007","journal-title":"J Virol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107493_b0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2021.107493_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv. Virus Res."},{"issue":"Pt 4","key":"10.1016\/j.intimp.2021.107493_b0105","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"Ziebuhr","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2021.107493_b0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","article-title":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation","volume":"14","author":"Haagmans","year":"2014","journal-title":"Lancet Infect. Dis"},{"key":"10.1016\/j.intimp.2021.107493_b0115","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to- human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2021.107493_b0120","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1128\/jvi.64.11.5367-5375.1990","article-title":"Assembly of coronavirus spike protein into trimers and its role in epitope expression","volume":"64","author":"Delmas","year":"1990","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107493_b0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nsmb1123","article-title":"Architecture of the SARS coronavirus prefusion spike","volume":"13","author":"Beniac","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"Pt 5","key":"10.1016\/j.intimp.2021.107493_b0130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/vir.0.80671-0","article-title":"Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E","volume":"86","author":"Nal","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107493_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","article-title":"A structural analysis of M protein in coronavirus assembly and morphology","volume":"174","author":"Neuman","year":"2011","journal-title":"J. Struct. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107493_b0140","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107493_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.intimp.2021.107493_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Meth. Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107493_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11373-005-9035-9","article-title":"Modular organization of SARS coronavirus nucleocapsid protein","volume":"13","author":"Chang","year":"2006","journal-title":"J. Biomed. Sci."},{"issue":"14","key":"10.1016\/j.intimp.2021.107493_b0160","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1128\/JVI.00440-09","article-title":"Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein","volume":"83","author":"Hurst","year":"2009","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.intimp.2021.107493_b0165","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3390\/cells9122638","article-title":"Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2","volume":"9","author":"Hatmal","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2021.107493_b0170","unstructured":"Jackson CB, Zhang L, Farzan M, Choe H. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein. Biochem Biophys Res Commun. (2020):S0006-291X(20)32074-X. doi: 10.1016\/j.bbrc.2020.11.026. Epub ahead of print. PMID: 33220921; PMCID: PMC7664360."},{"key":"10.1016\/j.intimp.2021.107493_b0175","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2021.107493_b0180","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0400576101","article-title":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides","volume":"101","author":"Bosch","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2021.107493_b0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.intimp.2021.107493_b0190","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMe1212300","article-title":"Emerging human coronaviruses-disease potential and preparedness","volume":"367","author":"Anderson","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2012.47","article-title":"Emerging virus diseases: can we ever expect the unexpected?","volume":"1","author":"Howard","year":"2012","journal-title":"Emerg. Microbes. Infect."},{"issue":"4","key":"10.1016\/j.intimp.2021.107493_b0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: Genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107493_b0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.intimp.2021.107493_b0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus\u2013Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0215","unstructured":"Coronavirus disease 2019 (COVID-19): situation report \u2014 36. Geneva: World Health Organization, February 25, 2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation -reports\/20200225-sitrep-36-covid-19.pdf?sfvrsn=2791b4e0_2."},{"key":"10.1016\/j.intimp.2021.107493_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.042","article-title":"Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster","author":"Ye","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.107493_b0225","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0230","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0235","unstructured":"Coronavirus disease 2019 (COVID-19) in the U.S. Atlanta: Centers for Disease Control and Prevention, February 26, 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-in-us.html."},{"issue":"5","key":"10.1016\/j.intimp.2021.107493_b0240","doi-asserted-by":"crossref","DOI":"10.3201\/eid2605.190995","article-title":"Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings \u2014 social distancing measures","volume":"26","author":"Fong","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.107493_b0245","unstructured":"W. Guan, Z. Ni, et al., 2020. Clinical Characteristics of Coronavirus Disease 2019 in China.n engl j med."},{"key":"10.1016\/j.intimp.2021.107493_b0250","first-page":"4","article-title":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","volume":"7","author":"Jin","year":"2020","journal-title":"Mil Med Res."},{"key":"10.1016\/j.intimp.2021.107493_b0255","article-title":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement","author":"Shen","year":"2020","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.intimp.2021.107493_b0260","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001191","article-title":"First Case of 2019 Novel Coronavirus in the United States","author":"Holshue","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0265","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Chaolin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107493_b0270","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2214\/ajr.180.5.1801247","article-title":"SARS: Imaging of Severe Acute Respiratory Syndrome","volume":"180","author":"Nicolaou","year":"2003","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.intimp.2021.107493_b0275","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2303030853","article-title":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients","volume":"230","author":"Ooi","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.intimp.2021.107493_b0280","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.gastro.2003.08.001","article-title":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection","volume":"125","author":"Leung","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2021.107493_b0285","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.15.14445","article-title":"Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients","volume":"205","author":"Das","year":"2015","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.intimp.2021.107493_b0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of Middle East respiratory syndrome coronavirus","volume":"369","author":"Assiri","year":"2013","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials."},{"key":"10.1016\/j.intimp.2021.107493_b0300","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1056\/NEJMe2001126","article-title":"Another decade, another coronavirus","volume":"382","author":"Perlman","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0305","unstructured":"CoVID-19 News Update National-Health-Commission-of-the-People\u2019s-Republic-of-China. up to 24 (February) 2020."},{"key":"10.1016\/j.intimp.2021.107493_b0310","first-page":"252000094","article-title":"First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020","author":"Stoecklin","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.intimp.2021.107493_b0315","unstructured":"WHO. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19-2 March 2020. Available at https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---2-march-2020."},{"issue":"18","key":"10.1016\/j.intimp.2021.107493_b0320","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","article-title":"Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies","volume":"77","author":"Dyall","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2021.107493_b0325","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2021.107493_b0330","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0335","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2021.107493_b0340","doi-asserted-by":"crossref","unstructured":"Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020 Aug;51(6):585-586. doi: 10.1016\/j.arcmed.2020.05.001. Epub 2020 May 12. PMID: 32439198; PMCID: PMC7214327.","DOI":"10.1016\/j.arcmed.2020.05.001"},{"key":"10.1016\/j.intimp.2021.107493_b0345","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2021.107493_b0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"J.2","author":"Vincent","year":"2005","journal-title":"Virol."},{"key":"10.1016\/j.intimp.2021.107493_b0355","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","article-title":"Dose refinements in long-term therapy of rheumatoid arthritis with anti malarials","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0360","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"29","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107493_b0365","doi-asserted-by":"crossref","unstructured":"Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC, Lee SS, Chakraborty C. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020 Jun;92(6):618-631. doi: 10.1002\/jmv.25736. Epub 2020 Mar 5. PMID: 32108359; PMCID: PMC7228377.","DOI":"10.1002\/jmv.25736"},{"key":"10.1016\/j.intimp.2021.107493_b0370","doi-asserted-by":"crossref","unstructured":"Bhattacharya M, Sharma AR, Mallick B, Sharma G, Lee SS, Chakraborty C. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4\/MD-2 complex. Infect Genet Evol. 2020 Nov;85:104587. doi: 10.1016\/j.meegid.2020.104587. Epub 2020 Oct 8. PMID: 33039603; PMCID: PMC7543713.","DOI":"10.1016\/j.meegid.2020.104587"},{"key":"10.1016\/j.intimp.2021.107493_b0375","unstructured":"European-Centre-for-Disease-Prevention-and-Control. Daily risk assessment on COVID-19, 2 March 2020 Available at: https:\/\/www.ecdc.europa.eu\/en\/current-risk-assessment-novel-coronavirus-situation."},{"key":"10.1016\/j.intimp.2021.107493_b0380","first-page":"514","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","author":"Fuk-Woo","year":"2020","journal-title":"The Lancet."},{"key":"10.1016\/j.intimp.2021.107493_b0385","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Mekhlafi GAACorticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome","volume":"197","author":"Arabi","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2021.107493_b0390","unstructured":"WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hern\u00e1ndez Garc\u00eda C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, Garc\u00eda PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portol\u00e9s A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, R\u00f8ttingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med. 2020 Dec 2:NEJMoa2023184. doi: 10.1056\/NEJMoa2023184. Epub ahead of print. PMID: 33264556; PMCID: PMC7727327."},{"key":"10.1016\/j.intimp.2021.107493_b0395","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0400","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe Covid-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2021.107493_b0405","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate Covid-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2021.107493_b0410","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"Goldman","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.intimp.2021.107493_b0415","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056\/NEJMoa2022926. Epub 2020 Oct 8. PMID: 33031652; PMCID: PMC7556338.","DOI":"10.1056\/NEJMoa2022926"},{"key":"10.1016\/j.intimp.2021.107493_b0420","unstructured":"RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020 Oct 5;396(10259):1345\u201352. doi: 10.1016\/S0140-6736(20)32013-4. Epub ahead of print. PMID: 33031764; PMCID: PMC7535623."},{"issue":"11","key":"10.1016\/j.intimp.2021.107493_b0425","article-title":"Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review","volume":"17","author":"Agarwal","year":"2020","journal-title":"Front Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2021.107493_b0430","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/10799900050163226","article-title":"Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers","volume":"20","author":"Buchwalder","year":"2000","journal-title":"J. Interferon. Cytokine Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.107493_b0435","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-020-03048-5","article-title":"Interferon beta-1a for COVID-19: critical importance of the administration route","volume":"24","author":"Jalkanen","year":"2020","journal-title":"Crit Care."},{"key":"10.1016\/j.intimp.2021.107493_b0440","doi-asserted-by":"crossref","unstructured":"Jalkanen J, Pettil\u00e4 V, Huttunen T, Hollm\u00e9n M, Jalkanen S. Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung. Intensive Care Med. 2020 Oct;46(10):1937-1940. doi: 10.1007\/s00134-020-06086-3. Epub 2020 May 19. PMID: 32430515; PMCID: PMC7235433.","DOI":"10.1007\/s00134-020-06086-3"},{"key":"10.1016\/j.intimp.2021.107493_b0445","doi-asserted-by":"crossref","unstructured":"Flammer JR, Dobrovolna J, Kennedy MA, Chinenov Y, Glass CK, Ivashkiv LB, Rogatsky I. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol Cell Biol. 2010 Oct;30(19):4564-74. doi: 10.1128\/MCB.00146-10. Epub 2010 Aug 2. PMID: 20679482; PMCID: PMC2950533.","DOI":"10.1128\/MCB.00146-10"},{"key":"10.1016\/j.intimp.2021.107493_b0450","unstructured":"26th WHO Regulatory Update on COVID-19 08 January 2021 file:\/\/\/C:\/Users\/HP1\/Downloads\/26th-WHO-regulatory-update-on-COVID-19_08Jan2021.pdf."},{"issue":"7","key":"10.1016\/j.intimp.2021.107493_b0455","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2471\/BLT.20.253591","article-title":"Variant analysis of SARS-CoV-2 genomes","volume":"98","author":"Koyama","year":"2020","journal-title":"Bull World Health Organ."},{"issue":"11","key":"10.1016\/j.intimp.2021.107493_b0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241535","article-title":"Variant analysis of 1,040 SARS-CoV-2 genomes","volume":"15","author":"Rouchka","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2021.107493_b0465","doi-asserted-by":"crossref","unstructured":"Junxian Ou, Zhonghua Zhou, Ruixue Dai, Shan Zhao, Xiaowei Wu, Jing Zhang, Wendong Lan, Lilian Cui, Jianguo Wu, Donald Seto, James Chodosh, Gong Zhang, Qiwei Zhang. Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity (2020). bioRxiv 2020.03.15.991844. https:\/\/doi.org\/10.1101\/2020.03.15.991844.","DOI":"10.1101\/2020.03.15.991844"},{"key":"10.1016\/j.intimp.2021.107493_b0470","unstructured":"European Centre for Disease Prevention and Control (ECDC) (21 January 2021). \u201cRisk related to the spread of new SARS-CoV-2 variants of concern in the EU\/EEA \u2013 first update\u201d (PDF). Stockholm: ECDC. Retrieved 24 January 2021."},{"key":"10.1016\/j.intimp.2021.107493_b0475","doi-asserted-by":"crossref","first-page":"1701e1718","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.intimp.2021.107493_b0480","doi-asserted-by":"crossref","first-page":"1950e1958","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins Struct. Funct. Bioinforma"},{"key":"10.1016\/j.intimp.2021.107493_b0485","doi-asserted-by":"crossref","unstructured":"Walker, A. Sarah; Vihta, Karina-Doris; Gethings, Owen; Pritchard, Emma; Jones, Joel; House, Thomas; Bell, Iain; Bell, John I.; et al. (15 January 2021). \u201cIncreased infections, but not viral burden, with a new SARS-CoV-2 variant\u201d. medRxiv. doi:10.1101\/2021.01.13.21249721.","DOI":"10.1101\/2021.01.13.21249721"},{"issue":"5","key":"10.1016\/j.intimp.2021.107493_b0490","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/pathogens9050324","article-title":"Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment","volume":"9","author":"Koyama","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.intimp.2021.107493_b0495","unstructured":"Kahn, Jeremy (22 January 2021). \u201cHighly transmissible U.K. virus strain is also 30% more lethal, Boris Johnson warns\u201d. Fortune."},{"key":"10.1016\/j.intimp.2021.107493_b0500","series-title":"Here\u2019s what we know about the new variant of coronavirus","author":"Peacock","year":"2020"},{"key":"10.1016\/j.intimp.2021.107493_b0505","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel Coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:31:37Z","timestamp":1761586297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":101,"alternative-id":["S1567576921001296"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107493","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis \u2013 An updated review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107493"}}